Merck and ChemLex announced the signing of a Memorandum of Understanding (MOU) to explore a strategic collaboration in evolving R&D paradigms. The MOU reflects a shared commitment to advancing life science and electronics discoveries by combining Merck's deep scientific and translational expertise with ChemLex's automated chemistry platform and data generation capabilities. Together, the parties aim to enhance the speed, efficiency, and reproducibility of chemical research across early discovery and development workflows within Merck's various business sectors. Under the framework of the MOU, Merck and ChemLex intend to explore areas of cooperation that may include automated synthesis, reaction optimization, high-throughput experimentation, and chemistry platform integration.

Initial efforts will focus on identifying high-impact chemistry programs and defining pathways toward potential future collaborations. The signing of the MOU underscores both organizations' interest in scalable, data-rich experimental science and their shared focus on building long-term partnerships that advance innovation at the intersection of chemistry and automation. The parties will continue discussions to evaluate next steps under the MOU framework.